French Software Stock News

Recent performance snapshot Planisware SAS (ENXTPA:PLNW) has caught investor attention after a recent move in its share price, with the stock showing a 3.3% return over the past day and 2.2% over the past week. See our latest analysis for Planisware SAS. The recent 27.3% 1 month share price return contrasts with a year to date share price return of negative 19.8% and a 1 year total shareholder return of negative 26.4%. This suggests short term momentum is picking up from a weak longer term...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Sopra Steria Group (ENXTPA:SOP) reported first quarter 2026 consolidated revenue of €1,463.2 million, compared with €1,418.3 million a year earlier, giving investors fresh insight into how its consulting and digital services business is tracking. See our latest analysis for Sopra Steria Group. The recent first quarter revenue update has come alongside a 21.47% 7 day share price return to €137.5. However, the year to date share price return of 8.82% and 1 year total shareholder return of...

Pierre et Vacances (ENXTPA:VAC) drew investor attention after reporting group revenue of €412.8 million for the second quarter of 2026 and €816.8 million for the first half, compared with €407.4 million and €802.1 million a year earlier. See our latest analysis for Pierre et Vacances. The latest trading statement appears to have coincided with improving momentum, with a 12.47% 1 month share price return and a 28.49% 1 year total shareholder return, contrasting with a weaker 5 year total...

Why JCDecaux is Back on Watchlists JCDecaux (ENXTPA:DEC) has drawn fresh attention after recent share price moves, with the stock showing positive total returns over the past month, past 3 months and year. This has prompted a closer look at its fundamentals. See our latest analysis for JCDecaux. The recent share price around €18.9 sits against a backdrop of a 22.57% year to date share price return and a 24.69% total shareholder return over the past year, suggesting momentum has been building...

Guidance confirmation and Q1 update Safran (ENXTPA:SAF) confirmed its full year 2026 earnings guidance, stating that it expects low to mid teens revenue growth. The company also reported first quarter consolidated revenue of €8,624 million, compared with €7,257 million a year earlier. See our latest analysis for Safran. Safran's confirmation of low to mid teens revenue growth for 2026 and its first quarter revenue of €8,624 million come as the stock trades at €273.0, with a 1 year total...

In April 2026, ERAMET S.A. reported first-quarter production results showing weaker manganese ore and mineral sands output but very large growth in lithium carbonate volumes, alongside modest gains in manganese alloys and nickel ore. The company also issued 2026 production guidance that highlights constrained nickel ore output pending regulatory approvals, while targeting higher lithium carbonate production. Against this backdrop, we will examine how the sharp increase in lithium carbonate...

As the European markets navigate a landscape of stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained relatively stable, with corporate earnings showing signs of positive momentum. In this environment, identifying stocks that might be trading below their fair value can be particularly appealing to investors seeking opportunities amidst broader economic uncertainties.

Shareholders appeared unconcerned with Sanofi's ( EPA:SAN ) lackluster earnings report last week. We think that the...

bioMérieux (ENXTPA:BIM) has put fresh data on the table, with a new Office of Health Economics study linking its fast ID/AST diagnostics to fewer sepsis cases and lower treatment costs across G7 health systems. See our latest analysis for bioMérieux. The new sepsis data lands at a time when bioMérieux’s €71.7 share price has a 1 day share price return of 5.05%, but a 30 day share price return of 23.44% decline and a 1 year total shareholder return of 39.10% decline, pointing to pressure that...

Inventiva (ENXTPA:IVA) reshaped its leadership team, appointing a new Chief Financial Officer, Chief Legal Officer, and Chief People Officer as it prepares for a key Phase 3 NATiV3 data readout later this year. See our latest analysis for Inventiva. The latest leadership reshuffle comes as the share price sits at €4.31, with a 6.55% year to date share price return but a 16.15% decline over 90 days. At the same time, the 1 year total shareholder return of 33.02% and 3 year total shareholder...

Why Ayvens’ Q1 earnings matter for shareholders Ayvens (ENXTPA:AYV) released first quarter 2026 results with sales of €2,810.8 million, compared with €2,846.3 million a year earlier, while net income was €266.5 million versus €219.9 million, drawing fresh attention to the stock. See our latest analysis for Ayvens. The Q1 earnings release appears to have reset sentiment, with the latest 1 day share price return of 5.13% and 1 month share price return of 9.75% contrasting with a 90 day share...

In its Q1 2026 earnings call on 30 April, TF1 reported a 5% revenue decline but highlighted resilient operations and a solid financial footing. A standout detail was the 22% year-on-year jump in TF1+ digital advertising revenue, helping lift total digital revenue by 18% and underscoring the importance of its Netflix tie-up and SME-focused ad tools. We’ll now examine how TF1’s strong TF1+ digital advertising growth might reshape the existing investment narrative around the group. Invest in...

Capgemini (ENXTPA:CAP) just released its Q1 2026 trading update, reporting revenue of €5,943 million versus €5,553 million a year earlier, supported by multi year cloud, AI and McDonald’s partnership deals. See our latest analysis for Capgemini. Despite the Q1 update and new cloud and AI agreements, momentum in Capgemini’s share price has been weak, with a 90 day share price return of a 23.31% decline and a 1 year total shareholder return of a 26.08% decline. This suggests investors are still...

Why SES Stock Is On Investors’ Radar Today SES (ENXTPA:SESG) has been drawing fresh attention after a solid run over the past year, with the share price showing gains over the past month, past 3 months and year to date. See our latest analysis for SES. The recent momentum in SES is hard to ignore, with a 30 day share price return of 10.71% and a year to date share price return of 23.66%. The 1 year total shareholder return of 65.42% highlights how dividends and other distributions have added...

On 21 April 2026, Vusion S.A. confirmed its 2026 group earnings guidance, forecasting total value-added services (VAS) revenue to rise by around 40%, driven by both recurring and non-recurring VAS momentum. This emphasis on fast-growing, higher-margin VAS underlines a shift in Vusion’s revenue mix toward more service-oriented, potentially stickier customer relationships. With this stronger VAS growth outlook now on the table, we’ll examine how it reshapes Vusion’s investment narrative and...

Accor SA recently reported first-quarter 2026 revenue of €1,313 million, slightly below the €1,349 million recorded in the same period a year earlier. Alongside this softer revenue print, Accor and partners are pushing into India’s lifestyle segment with The Hoxton, Bengaluru City, scheduled to open in November 2026. Next, we’ll examine how the softer first-quarter revenue figure shapes Accor’s investment narrative built around asset-light expansion and earnings quality. Capitalize on the AI...

As you might know, TotalEnergies SE ( EPA:TTE ) just kicked off its latest quarterly results with some very strong...

If you are wondering whether Schneider Electric's current share price fairly reflects its fundamentals, a useful starting point is to look closely at what the recent numbers might be telling you about value and risk. The stock recently closed at €268.60, with returns of 13.7% over 30 days, 13.3% year to date, 26.7% over 1 year, 78.5% over 3 years, and 118.9% over 5 years. This naturally raises questions about how much of this performance is already priced in. Recent news flow around...

Euronext’s recent performance snapshot Euronext (ENXTPA:ENX) has drawn investor attention after a mixed return profile, with a small 1 day decline, a modest pullback over the week and month, and a gain of about 20% over the past 3 months. See our latest analysis for Euronext. At a share price of €142.9, Euronext’s recent pullback sits against a much stronger 90 day share price return of 20.49% and multi year total shareholder returns that remain firmly positive, which suggests sentiment has...

China Southern Airlines and its subsidiary placed an order for 137 Airbus A320neo-family jets, further expanding their single aisle fleet plans. The European Commission granted regulatory approval for a global A350 component maintenance joint venture between Airbus and Air France KLM. These developments highlight commercial demand for Airbus aircraft and an expansion of its role in long term support services for the A350 platform. For investors tracking ENXTPA:AIR, the twin updates touch...

Pernod Ricard (ENXTPA:RI) has ended merger talks with US spirits group Brown Forman, halting discussions that could have reshaped the global drinks sector. The company has also launched its first large scale TikTok marketing campaign, focusing on younger adult consumers and new digital engagement formats. These developments follow a period where recent coverage has centred on ENXTPA:RI’s valuation and share price rather than its corporate moves and brand building efforts. Pernod Ricard, the...

Q1 2026 revenue update and why it matters for shareholders Fnac Darty (ENXTPA:FNAC) reported first quarter 2026 revenue of €2,309.8 million compared with €2,285.8 million a year earlier, giving investors fresh information on how its retail business is currently performing. See our latest analysis for Fnac Darty. The latest trading statement comes after a solid year to date, with a year to date share price return of 20.48% contrasting with a five year total shareholder return decline of...

ABIVAX Société Anonyme (ENXTPA:ABVX) is back in focus after its recent update on the Phase 3 ABTECT-UC trial for ulcerative colitis, its extended cash runway into Q4 2027, and the appointment of new commercial leadership. See our latest analysis for ABIVAX Société Anonyme. The recent Phase 3 update and extended cash runway appear to sit against fading short term momentum, with a 30 day share price return of 4.88% decline and year to date share price return of 16.13% decline. At the same time,...